Literature DB >> 946383

Congenital graves disease. Four familial cases with long-term follow-up and perspective.

D R Hollingsworth, C C Mabry.   

Abstract

Congenital Graves disease has been described as a transient disorder in which the mother has or has had hyperthyroidism. Experience with four affected children to ages 5 to 9 years and a review of published cases led us to conclude that long-acting thyroid stimulator (half-life, six days) is not the cause of the disease. This disease occurs in infants from families with a high incidence of Graves disease, and, in many, hyperthyroidism persists for months or years. The pathogenesis of Graves disease is unknown, and the simplistic maternal-to-fetal humoral theory is not a suitable explanation for congenital Graves disease. If Graves disease is considered in the larger perspective than the maternal-fetal unit, a pattern of inheritance is apparent, ie, an autosomal-dominant trait with a predilection for the female individual.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946383     DOI: 10.1001/archpedi.1976.02120030038008

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  10 in total

1.  Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years.

Authors:  Shannon E Scratch; Rodney W Hunt; Deanne K Thompson; Zohra M Ahmadzai; Lex W Doyle; Terrie E Inder; Peter J Anderson
Journal:  Pediatrics       Date:  2014-03-31       Impact factor: 7.124

2.  Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors:  J Ginsberg; C von Westarp
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

Review 3.  Pathogenesis of neonatal Graves' disease.

Authors:  J M McKenzie; M Zakarija
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

4.  Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosis.

Authors:  J M Wit; B Rees-Smith; F M Creagh; H W Bruinse; D van der Heide; R Docter; L J Gerards
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Graves' disease associated with exophthalmos, cerebral ventricular dilatation and accelerated growth.

Authors:  O Arisaka; A Hosaka; H Arai; S Fujiwara; R Tadokoro; K Yabuta
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

Review 6.  Neuropsychiatric aspects of pediatric thyrotoxicosis.

Authors:  V S Bhatara; R Sankar
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

7.  Neonatal thyrotoxicosis treated with exchange transfusion and Lugol's iodine.

Authors:  J M Wit; L J Gerards; C Vermeulen-Meiners; H W Bruinse
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

Review 8.  Neonatal thyroid disorders.

Authors:  A L Ogilvy-Stuart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

Review 9.  Fetal and neonatal thyrotoxicosis.

Authors:  Chandar Mohan Batra
Journal:  Indian J Endocrinol Metab       Date:  2013-10

10.  Methimazole associated neutropenia in a preterm neonate treated for hyperthyroidism.

Authors:  Dimitrios Angelis; Rita Ann Kubicky; Alan B Zubrow
Journal:  Case Rep Endocrinol       Date:  2015-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.